LUXIA PHARMA LTD
LUXIA PHARMA LTD is a Private limited company (Ltd.) registered in United Kingdom under 15903155, and its current status with Companies House is active. The company was incorporated on 19 August 2024 and lists its registered address as Wembley, United Kingdom. 1 shareholder is on record for LUXIA PHARMA LTD, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Companies House and was last updated on 1 November 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for LUXIA PHARMA LTD, held on the Confirmation Statement (CS01), filed under the Companies Act 2006.
The largest of these is DS HOLDINGS GROUP LTD, holding 100% — a majority holding.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| DS HOLDINGS GROUP LTD | 100% | Companies House |
Officers
2
One of the 2 officer records shown for LUXIA PHARMA LTD is a current appointment, filed with Companies House. Daniel Sheehy (appointed 2024-08-19) serves as Director. The remaining 1 record shown (Lucia McLaughlan) is a former appointment that has since been resigned.
Management authority at LUXIA PHARMA LTD sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
LUXIA PHARMA LTD sits 1 level below its ultimate parent, DS HOLDINGS GROUP LTD, registered in United Kingdom. Immediately above LUXIA PHARMA LTD is DS HOLDINGS GROUP LTD, holding 100% as filed in LUXIA PHARMA LTD's own shareholder record with Companies House.
DS HOLDINGS GROUP LTD
United Kingdom
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns LUXIA PHARMA LTD?
One shareholder is currently on record for LUXIA PHARMA LTD, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is DS HOLDINGS GROUP LTD, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is LUXIA PHARMA LTD's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for LUXIA PHARMA LTD is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does LUXIA PHARMA LTD have on record?
1 shareholder is shown on record for LUXIA PHARMA LTD.
What is LUXIA PHARMA LTD's company registration number?
LUXIA PHARMA LTD's registration number is 15903155, filed with Companies House in United Kingdom. Its current status on the register is active.
Is LUXIA PHARMA LTD still an active company?
LUXIA PHARMA LTD's status on Companies House is listed as active.
When was LUXIA PHARMA LTD incorporated?
LUXIA PHARMA LTD was incorporated on 19 August 2024, according to Companies House.
What is LUXIA PHARMA LTD's registered address?
The registered address on file for LUXIA PHARMA LTD is Wembley, United Kingdom.
What legal structure is LUXIA PHARMA LTD registered as?
LUXIA PHARMA LTD is registered as a Private limited company (Ltd.) in United Kingdom.
Who are the officers/directors of LUXIA PHARMA LTD?
One of the 2 officer records shown for LUXIA PHARMA LTD is a current appointment, filed with Companies House. Daniel Sheehy (appointed 2024-08-19) serves as Director. The remaining 1 record shown (Lucia McLaughlan) is a former appointment that has since been resigned. Management authority at LUXIA PHARMA LTD sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does LUXIA PHARMA LTD have a parent company or subsidiaries?
LUXIA PHARMA LTD sits 1 level below its ultimate parent, DS HOLDINGS GROUP LTD, registered in United Kingdom.
Can Zavia monitor changes to LUXIA PHARMA LTD's ownership over time?
This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to LUXIA PHARMA LTD's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access LUXIA PHARMA LTD's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like LUXIA PHARMA LTD's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Companies House and was last synced on 1 November 2026.